---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-090627"
form_type: "8-K"
ticker: "TNON"
cik: "0001560293"
company_name: "Tenon Medical, Inc."
filed_at: "2025-09-23T23:59:59+00:00"
generated_at: "2026-05-17T05:52:38.465606+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tenon Medical shareholders approve warrant exercisability and equity plan increase at 2025 annual meeting

## Summary
- All seven director nominees elected: Ferrari, Foster, Ginn, Hochschuler, Howard, Jacques, Weigle each received >2.48M votes for.
- Approved exercisability of Series C-1 (up to 2,445,700 shares) and C-2 (up to 1,222,850 shares) warrants at $1.25/share; 2,517,314 for, 120,940 against.
- 2022 Equity Incentive Plan amendments approved: share reserve increased from 189,870 to 1,328,365 shares; evergreen provision modified to up to 4% outstanding annually.
- Ratified Haskell & White LLP as independent auditor for FY2025 with 4,488,067 votes for.

## SEC filing metadata
- accession: 0001213900-25-090627
- form_type: 8-K
- ticker: TNON
- cik: 0001560293
- company_name: Tenon Medical, Inc.
- filed_at: 2025-09-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560293/000121390025090627/0001213900-25-090627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560293/000121390025090627/ea0258406-8k_tenon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-090627
- JSON: https://secwatch.observer/filing/0001213900-25-090627.json
- Plain text: https://secwatch.observer/filing/0001213900-25-090627.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.